227 related articles for article (PubMed ID: 14511676)
1. Oxidized neprilysin in aging and Alzheimer's disease brains.
Wang DS; Iwata N; Hama E; Saido TC; Dickson DW
Biochem Biophys Res Commun; 2003 Oct; 310(1):236-41. PubMed ID: 14511676
[TBL] [Abstract][Full Text] [Related]
2. The antioxidant xanthorrhizol prevents amyloid-β-induced oxidative modification and inactivation of neprilysin.
Lim CS; Han JS
Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29330223
[TBL] [Abstract][Full Text] [Related]
3. Decreased neprilysin immunoreactivity in Alzheimer disease, but not in pathological aging.
Wang DS; Lipton RB; Katz MJ; Davies P; Buschke H; Kuslansky G; Verghese J; Younkin SG; Eckman C; Dickson DW
J Neuropathol Exp Neurol; 2005 May; 64(5):378-85. PubMed ID: 15892294
[TBL] [Abstract][Full Text] [Related]
4. Effects of HNE-modification induced by Abeta on neprilysin expression and activity in SH-SY5Y cells.
Wang R; Wang S; Malter JS; Wang DS
J Neurochem; 2009 Feb; 108(4):1072-82. PubMed ID: 19196432
[TBL] [Abstract][Full Text] [Related]
5. A combination Alzheimer's therapy targeting BACE1 and neprilysin in 5XFAD transgenic mice.
Devi L; Ohno M
Mol Brain; 2015 Mar; 8():19. PubMed ID: 25884928
[TBL] [Abstract][Full Text] [Related]
6. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
[TBL] [Abstract][Full Text] [Related]
7. N-acetylcysteine prevents 4-hydroxynonenal- and amyloid-beta-induced modification and inactivation of neprilysin in SH-SY5Y cells.
Wang R; Malter JS; Wang DS
J Alzheimers Dis; 2010; 19(1):179-89. PubMed ID: 20061637
[TBL] [Abstract][Full Text] [Related]
8. Neprilysin degrades murine Amyloid-β (Aβ) more efficiently than human Aβ: Further implication for species-specific amyloid accumulation.
Becker M; Moore A; Naughton M; Boland B; Siems WE; Walther T
Neurosci Lett; 2018 Nov; 686():74-79. PubMed ID: 30144539
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy.
Miners JS; Van Helmond Z; Chalmers K; Wilcock G; Love S; Kehoe PG
J Neuropathol Exp Neurol; 2006 Oct; 65(10):1012-21. PubMed ID: 17021406
[TBL] [Abstract][Full Text] [Related]
10. Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer's brain.
Wang S; Wang R; Chen L; Bennett DA; Dickson DW; Wang DS
J Neurochem; 2010 Oct; 115(1):47-57. PubMed ID: 20663017
[TBL] [Abstract][Full Text] [Related]
11. Neprilysin inhibitors and risk of Alzheimer's disease: A future perspective.
Ali NH; Al-Kuraishy HM; Al-Gareeb AI; Alnaaim SA; Alexiou A; Papadakis M; Khalifa AA; Saad HM; Batiha GE
J Cell Mol Med; 2024 Jan; 28(2):e17993. PubMed ID: 37847125
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation level of the neprilysin promoter in Alzheimer's disease brains.
Nagata K; Mano T; Murayama S; Saido TC; Iwata A
Neurosci Lett; 2018 Mar; 670():8-13. PubMed ID: 29339171
[TBL] [Abstract][Full Text] [Related]
13. Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β.
Tayler H; Fraser T; Miners JS; Kehoe PG; Love S
J Alzheimers Dis; 2010; 22(4):1363-73. PubMed ID: 20930272
[TBL] [Abstract][Full Text] [Related]
14. Distinct subcellular patterns of neprilysin protein and activity in the brains of Alzheimer's disease patients, transgenic mice and cultured human neuronal cells.
Zhou L; Wei C; Huang W; Bennett DA; Dickson DW; Wang R; Wang D
Am J Transl Res; 2013; 5(6):608-21. PubMed ID: 24093058
[TBL] [Abstract][Full Text] [Related]
15. Anti-amyloid activity of neprilysin in plaque-bearing mouse models of Alzheimer's disease.
Mohajeri MH; Kuehnle K; Li H; Poirier R; Tracy J; Nitsch RM
FEBS Lett; 2004 Mar; 562(1-3):16-21. PubMed ID: 15043995
[TBL] [Abstract][Full Text] [Related]
16. Recombinant soluble neprilysin reduces amyloid-beta accumulation and improves memory impairment in Alzheimer's disease mice.
Park MH; Lee JK; Choi S; Ahn J; Jin HK; Park JS; Bae JS
Brain Res; 2013 Sep; 1529():113-24. PubMed ID: 23831521
[TBL] [Abstract][Full Text] [Related]
17. Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders.
Caccamo A; Oddo S; Sugarman MC; Akbari Y; LaFerla FM
Neurobiol Aging; 2005 May; 26(5):645-54. PubMed ID: 15708439
[TBL] [Abstract][Full Text] [Related]
18. Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.
Jha NK; Jha SK; Kumar D; Kejriwal N; Sharma R; Ambasta RK; Kumar P
J Alzheimers Dis; 2015; 48(4):891-917. PubMed ID: 26444774
[TBL] [Abstract][Full Text] [Related]
19. Brain neprilysin activity and susceptibility to transgene-induced Alzheimer amyloidosis.
Carter TL; Pedrini S; Ghiso J; Ehrlich ME; Gandy S
Neurosci Lett; 2006 Jan; 392(3):235-9. PubMed ID: 16233955
[TBL] [Abstract][Full Text] [Related]
20. Possible role of resveratrol targeting estradiol and neprilysin pathways in lipopolysaccharide model of Alzheimer disease.
El-Sayed NS; Bayan Y
Adv Exp Med Biol; 2015; 822():107-18. PubMed ID: 25416980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
